Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Just

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Journal of Forensic Sciences|June 3, 2009
The use of mitochondrial DNA single nucleotide polymorphisms to assist in the resolution of three challenging forensic casesRebecca S Just, Mark D Leney, Suzanne M Barritt, et al.
Leukemia|January 12, 2017
Gain of function in Jak2<sup>V617F</sup>-positive T-cellsG Nishanth, D Wolleschak, C Fahldieck, et al.
Journal of the American Medical Directors Association|September 5, 2024
Association of Polymorphic Cytochrome P450 Enzyme Pathways with Falls in Multimedicated Older AdultsKatja S Just, Laura M Pott, Jakob Sommer, et al.
British Journal of Clinical Pharmacology|February 21, 2026
The quantitative impact of metabolism-inhibiting drugs on the occurrence of adverse drug reactions-A backward selection approachJudith Berres, Justyna Wozniak, Hannah Fölsch, et al.
European Journal of Clinical Pharmacology|April 22, 2026
Association of high risk of liver fibrosis in patients with serious outcomes of adverse drug reactionsJoana Henze, Harald Dormann, Carolin V Schneider, et al.
Clinical Pharmacology and Therapeutics|November 16, 2023
Nutrimetric Validation of Solanidine as Dietary-Derived CYP2D6 Activity Marker In VivoJulian Peter Müller, Jens Sarömba, Patrick Ziegler, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System?Katja S Just, Catharina Scholl, Miriam Boehme, et al.
Journal of Clinical Medicine|June 13, 2020
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED StudyKatja S Just, Harald Dormann, Marlen Schurig, et al.
Deutsches Arzteblatt International|May 9, 2018
Adverse Drug Reactions (ADR) and EmergenciesA Marlen Schurig, Miriam Böhme, Katja S Just, et al.
Forensic Science International. Genetics|May 16, 2017
Internal validation of STRmix™ for the interpretation of single source and mixed DNA profilesTamyra R Moretti, Rebecca S Just, Susannah C Kehl, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Journal of Forensic Sciences|June 3, 2009
The use of mitochondrial DNA single nucleotide polymorphisms to assist in the resolution of three challenging forensic casesRebecca S Just, Mark D Leney, Suzanne M Barritt, et al.
Leukemia|January 12, 2017
Gain of function in Jak2<sup>V617F</sup>-positive T-cellsG Nishanth, D Wolleschak, C Fahldieck, et al.
Journal of the American Medical Directors Association|September 5, 2024
Association of Polymorphic Cytochrome P450 Enzyme Pathways with Falls in Multimedicated Older AdultsKatja S Just, Laura M Pott, Jakob Sommer, et al.
British Journal of Clinical Pharmacology|February 21, 2026
The quantitative impact of metabolism-inhibiting drugs on the occurrence of adverse drug reactions-A backward selection approachJudith Berres, Justyna Wozniak, Hannah Fölsch, et al.
European Journal of Clinical Pharmacology|April 22, 2026
Association of high risk of liver fibrosis in patients with serious outcomes of adverse drug reactionsJoana Henze, Harald Dormann, Carolin V Schneider, et al.
Clinical Pharmacology and Therapeutics|November 16, 2023
Nutrimetric Validation of Solanidine as Dietary-Derived CYP2D6 Activity Marker In VivoJulian Peter Müller, Jens Sarömba, Patrick Ziegler, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System?Katja S Just, Catharina Scholl, Miriam Boehme, et al.
Journal of Clinical Medicine|June 13, 2020
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED StudyKatja S Just, Harald Dormann, Marlen Schurig, et al.
Deutsches Arzteblatt International|May 9, 2018
Adverse Drug Reactions (ADR) and EmergenciesA Marlen Schurig, Miriam Böhme, Katja S Just, et al.
Forensic Science International. Genetics|May 16, 2017
Internal validation of STRmix™ for the interpretation of single source and mixed DNA profilesTamyra R Moretti, Rebecca S Just, Susannah C Kehl, et al.
Pageof 13